EXP Pharmaceutical Services Corp., the nation's best-in-class provider of pharmacy services, announces a strategic partnership with Capital Inventory, Inc., the nation's premier hospital pharmacy inventory services company.The EXP-Capital Inventory partnership stems from both companies' recognition of the industry's need for an effective solution that will allow hospitals to secure the gold-standard third-party audit of physical pharmaceutical inventory."EXP has seen the increasing need among our hospital customers for wall-to-wall physical pharmacy inventory service excellence. Capital Inventory addresses that need; and we are very excited to offer a solution that will empower our clients to secure and rely on the highest quality of service, receive comprehensive reporting and obtain these from personnel who are the most experienced in hospital pharmacy inventories," said Gus Changaris, EXP's Chief Executive Officer.Through this partnership, EXP's clientele will be offered market-leading value and service. This inventory solution is performed by inventory specialists who are the most experienced in hospital pharmacy inventory service. "And that makes a significant difference throughout the total inventory experience. There are so many specifics unique to hospital pharmacies that true professionals, specializing in hospital pharmacy inventories only, offer substantial advantages," stated Kirk Herweck, Vice President, Business Development, Corporate Accounts and Marketing.EXP serves 70% of the U.S. hospital-based Reverse Distribution Market, represented by the many thousands of hospital customers. In addition to its well-established market dominance, EXP also has one of the most experienced regulatory-compliance staffs in the industry. EXP will actively offer and provide details of the Capital Inventory solution in each of its client consultations."EXP's market leadership is a key component to this partnership. Instantly, Capital Inventory's service is actively marketed in conjunction with EXP's service to over 70% of U.S. hospitals. We applaud EXP for taking a stand in delivering to their customers the premier provider for third-party inventory audits," said Duran Dunn, Capital Inventory's President.EXP and Capital Inventory offer the most experienced inventory staff in the industry with the average team leader possessing over 10 years of experience in hospital pharmacies which is critical when considering pricing, package sizes, pharmacy layout, pharmacy processes, dispensing automation and pharmacy staff.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment